Immunogenicity rates after sars-cov-2 three-dose vaccination in patients under dialysis: a systematic review and meta-analysis

HIGHLIGHTS

  • who: Xiuhong Yang and colleagues from the Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Gong Wei Road, Shanghai, China have published the research work: Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis, in the Journal: Vaccines 2022, 2070 of 31/08/2022
  • what: Background: Considering the indeterminate effects following the administration of three doses of the SARS-CoV-2 vaccine to patients under dialysis this study aimed to evaluate the rates of patients who received the three-dose vaccine.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?